| P50 | author | Oliberto Sánchez | Q80111807 |
| | Mislay Avila | Q114407265 |
| P2093 | author name string | María P Rodríguez | |
| | Jorge R Toledo | |
| | Maritza Barrera | |
| | Omar Farnós | |
| | María Frías | |
| | Ernesto Vega | |
| | Patricia Domínguez | |
| | Henry Tait | |
| P2860 | cites work | The E2 glycoprotein of classical swine fever virus is a virulence determinant in swine. | Q27469449 |
| | Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer | Q27486595 |
| | Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination | Q33335898 |
| | Introduction to classical swine fever: virus, disease and control policy | Q33900769 |
| | Economic aspects of the control of classical swine fever outbreaks in the European Union | Q33900804 |
| | Laboratory diagnosis, epizootiology, and efficacy of marker vaccines in classical swine fever: a review | Q34087342 |
| | Heterologous gene expression from transmissible gastroenteritis virus replicon particles | Q34328584 |
| | Clinical signs and epidemiology of classical swine fever: a review of new knowledge | Q35078399 |
| | Vaccinology of classical swine fever: from lab to field | Q35576473 |
| | Vaccination against classical swine fever virus: limitations and new strategies | Q36177358 |
| | Marker vaccine strategies and candidate CSFV marker vaccines | Q36578325 |
| | Recent advances in the development of recombinant vaccines against classical swine fever virus: cellular responses also play a role in protection | Q36931230 |
| | Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge. | Q38294607 |
| | N-glycosylation pattern of E2 glycoprotein from classical swine fever virus | Q39903843 |
| | Highly protective E2-CSFV vaccine candidate produced in the mammary gland of adenoviral transduced goats. | Q40043397 |
| | Origin and evolution of viruses causing classical swine fever in Cuba. | Q40426196 |
| | A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge. | Q40508967 |
| | Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV. | Q40510511 |
| | Classical swine fever virus Strain 'C'. How long is it detectable after oral vaccination? | Q40524782 |
| | Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV. | Q40587942 |
| | Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs | Q40596619 |
| | Secretory pathway limits the enhanced expression of classical swine fever virus E2 glycoprotein in insect cells | Q40607316 |
| | An experimental infection with classical swine fever in E2 sub-unit marker-vaccine vaccinated and in non-vaccinated pigs. | Q40613725 |
| | Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus | Q40628191 |
| | Production of monoclonal antibodies against swine fever virus and their use in laboratory diagnosis | Q40807127 |
| | Propagation of hog cholera virus in rabbits. | Q41087629 |
| | Efficacy of an inactivated feline leukemia virus vaccine | Q41177731 |
| | Haemorrhagic septicaemia vaccines | Q47773396 |
| P433 | issue | 1 | |
| P921 | main subject | classical swine fever | Q19000581 |
| P304 | page(s) | 25-32 | |
| P577 | publication date | 2009-06-30 | |
| P1433 | published in | Veterinary Immunology and Immunopathology | Q7923704 |
| P1476 | title | Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats | |
| P478 | volume | 133 | |